CSCI.TO COSCIENS Biopharma Inc.

Healthcare Biotechnology Toronto Exchange
8.50 CAD
Close of Nov 7, 2026
3.30 14.80
Market cap
CAD 8.48M
P/E
-
P/B
0.40x
ROE
-9.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CSCI.TO undervalued?

Graham number

The Graham number of COSCIENS Biopharma Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

COSCIENS Biopharma Inc. fundamental analysis

No fundamental analysis for COSCIENS Biopharma Inc. yet.

COSCIENS Biopharma Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from …

Full company profile